From Wikipedia, the free encyclopedia
|Systematic (IUPAC) name|
|oral, intranasal, rectal|
|(what is this?)|
Prolintane (Catovit, Promotil, Villescon) is a stimulant and norepinephrine-dopamine reuptake inhibitor developed in the 1950s. It is closely related in chemical structure to other drugs such as pyrovalerone, MDPV, and propylhexedrine and it has a similar mechanism of action. Prolintane has a good safety profile and has been used even by the elderly. Prolintane is suitable for use up to once a week. Frequent use will cause it to lose effectiveness. Many cases of prolintane abuse have been reported, albeit mostly in European countries.
- α-PVP (β-ketone-prolintane, prolintanone)
- Methylenedioxypyrovalerone (MDPV)
- Pyrovalerone (Centroton, Thymergix)
- Hollister, L. E.; Gillespie, H. K. (1970). "A new stimulant, prolintane hydrochloride, compared with dextroamphetamine in fatigued volunteers". The Journal of Clinical Pharmacology 10 (2): 103–109. doi:10.1177/009127007001000205. PMID 4392006.
- GB Patent 807835
- Nicholson, A. N.; Stone, B. M.; Jones, M. M. (1980). "Wakefullness and reduced rapid eye movement sleep: Studies with prolintane and pemoline". British Journal of Clinical Pharmacology 10 (5): 465–472. doi:10.1111/j.1365-2125.1980.tb01790.x. PMC 1430138. PMID 7437258.
- Kyle, P. B.; Daley, W. P. (2007). "Domestic Abuse of the European Rave Drug Prolintane". Journal of Analytical Toxicology 31 (7): 415–418. doi:10.1093/jat/31.7.415. PMID 17725890.
|This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.|